Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis
in the Pancreas in Patients after Bariatric Surgery: a
Retrospective Study

J 2022

Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study

BLAHO, Martin, Jitka MACHACKOVA, Petr DÍTĚ, Pavol HOLECZY, Petr SEDIVY et. al.

Basic information

Original name

Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study

Authors

BLAHO, Martin (203 Czech Republic), Jitka MACHACKOVA (203 Czech Republic), Petr DÍTĚ (203 Czech Republic, belonging to the institution), Pavol HOLECZY, Petr SEDIVY (203 Czech Republic), Robert PSAR (203 Czech Republic), Zdenek SVAGERA (203 Czech Republic), Dominik VILIMEK (203 Czech Republic), Daniel TOMAN (203 Czech Republic), Ondrej URBAN (203 Czech Republic) and Marek BUZGA (203 Czech Republic)

Edition

OBESITY SURGERY, NEW YORK, SPRINGER, 2022, 0960-8923

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30219 Gastroenterology and hepatology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 2.900

RIV identification code

RIV/00216224:14110/22:00128219

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1007/s11695-022-06278-4

UT WoS

000859286600001

Keywords in English

Obesity; Bariatric surgery; Metabolic syndrome; Pancreatic steatosis

Abstract

V originále

invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. Methods Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. Results We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue ( VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. Conclusions Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.

Citovat

BLAHO, Martin, Jitka MACHACKOVA, Petr DÍTĚ, Pavol HOLECZY, Petr SEDIVY, Robert PSAR, Zdenek SVAGERA, Dominik VILIMEK, Daniel TOMAN, Ondrej URBAN and Marek BUZGA. Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study. OBESITY SURGERY. NEW YORK: SPRINGER, 2022, vol. 32, No 11, p. 3666-3674. ISSN 0960-8923. Available from: https://dx.doi.org/10.1007/s11695-022-06278-4.

@article{2249107,
   author = {Blaho, Martin and Machackova, Jitka and Dítě, Petr and Holeczy, Pavol and Sedivy, Petr and Psar, Robert and Svagera, Zdenek and Vilimek, Dominik and Toman, Daniel and Urban, Ondrej and Buzga, Marek},
   article_location = {NEW YORK},
   article_number = {11},
   doi = {http://dx.doi.org/10.1007/s11695-022-06278-4},
   keywords = {Obesity; Bariatric surgery; Metabolic syndrome; Pancreatic steatosis},
   language = {eng},
   issn = {0960-8923},
   journal = {OBESITY SURGERY},
   title = {Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study},
   url = {https://link.springer.com/article/10.1007/s11695-022-06278-4},
   volume = {32},
   year = {2022}
}

TY  - JOUR
ID  - 2249107
AU  - Blaho, Martin - Machackova, Jitka - Dítě, Petr - Holeczy, Pavol - Sedivy, Petr - Psar, Robert - Svagera, Zdenek - Vilimek, Dominik - Toman, Daniel - Urban, Ondrej - Buzga, Marek
PY  - 2022
TI  - Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study
JF  - OBESITY SURGERY
VL  - 32
IS  - 11
SP  - 3666-3674
EP  - 3666-3674
PB  - SPRINGER
SN  - 09608923
KW  - Obesity
KW  - Bariatric surgery
KW  - Metabolic syndrome
KW  - Pancreatic steatosis
UR  - https://link.springer.com/article/10.1007/s11695-022-06278-4
N2  - invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. Methods Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. Results We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue ( VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. Conclusions Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.
ER  -

BLAHO, Martin, Jitka MACHACKOVA, Petr DÍTĚ, Pavol HOLECZY, Petr SEDIVY, Robert PSAR, Zdenek SVAGERA, Dominik VILIMEK, Daniel TOMAN, Ondrej URBAN and Marek BUZGA. Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study. \textit{OBESITY SURGERY}. NEW YORK: SPRINGER, 2022, vol.~32, No~11, p.~3666-3674. ISSN~0960-8923. Available from: https://dx.doi.org/10.1007/s11695-022-06278-4.

Detailed Information on Publication Record